Department of Cardiothoracic Surgery, University of Cologne, Kerpener Strasse 62, D-50937, Cologne, Germany.
Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
BMC Cardiovasc Disord. 2020 Feb 3;20(1):47. doi: 10.1186/s12872-020-01338-y.
Cardiac surgery for prosthetic valve endocarditis (PVE) is associated with substantial mortality. We aimed to analyze 30-day and 1-year outcome in patients undergoing surgery for PVE and sought to identify preoperative risk factors for mortality with special regard to perivalvular infection.
We retrospectively analyzed data of 418 patients undergoing valve surgery for infective endocarditis between January 2009 and July 2018. After 1:1 propensity matching 158 patients (79 PVE/79 NVE) were analyzed with regard to postoperative 30-day and 1-year outcomes. Univariate and multivariable analyses were performed to identify potential risk factors for mortality.
315 patients (75.4%) underwent surgery for NVE and 103 (24.6%) for PVE. After propensity matching groups were comparable with regard to preoperative characteristics, clinical presentation and microbiological findings, except a higher incidence of perivalvular infection in patients with PVE (51.9%) compared to NVE (26.6%) (p = 0.001), longer cardiopulmonary bypass (166 [76-130] vs. 97 [71-125] min; p < 0.001) and crossclamp time (95 [71-125] vs. 68 [55-85] min; p < 0.001). Matched patients with PVE showed a 4-fold increased 30-day mortality (20.3%) in comparison with NVE patients (5.1%) (p = 0.004) and 2-fold increased 1-year mortality (PVE 29.1% vs. NVE 13.9%; p = 0.020). Multivariable analysis revealed perivalvular abscess, sepsis, preoperative AKI and PVE as independent risk factors for mortality. Patients with perivalvular abscess had a significantly higher 30-day mortality (17.7%) compared to patients without perivalvular abscess (8.0%) (p = 0.003) and a higher rate of perioperative complications (need for postoperative pacemaker implantation, postoperative cerebrovascular events, postoperative AKI). However, perivalvular abscess did not influence 1-year mortality (20.9% vs. 22.3%; p = 0.806), or long-term complications such as readmission rate or relapse of IE.
Patients undergoing surgery for PVE had a significantly higher 30-day and 1-year mortality compared to NVE. After propensity-matching 30-day mortality was still 4-fold increased in PVE compared to NVE. Patients with perivalvular abscess showed a significantly higher 30-day mortality and perioperative complications, whereas perivalvular abscess seems to have no relevant impact on 1-year mortality, the rate of readmission or relapse of IE.
心脏手术治疗人工瓣膜心内膜炎(PVE)与较高的死亡率相关。我们旨在分析 PVE 患者手术 30 天和 1 年的结果,并特别关注瓣周感染的术前风险因素。
我们回顾性分析了 2009 年 1 月至 2018 年 7 月期间接受瓣膜手术治疗感染性心内膜炎的 418 名患者的数据。经 1:1 倾向匹配后,分析了 158 名患者(79 名 PVE/79 名 NVE)术后 30 天和 1 年的结局。进行单变量和多变量分析,以确定死亡的潜在风险因素。
315 名患者(75.4%)因 NVE 而接受手术,103 名患者(24.6%)因 PVE 而接受手术。经倾向匹配后,两组患者在术前特征、临床表现和微生物学发现方面具有可比性,但 PVE 患者的瓣周感染发生率(51.9%)明显高于 NVE 患者(26.6%)(p=0.001),体外循环时间(166 [76-130] vs. 97 [71-125] 分钟;p<0.001)和主动脉阻断时间(95 [71-125] vs. 68 [55-85] 分钟;p<0.001)更长。PVE 患者的 30 天死亡率(20.3%)是 NVE 患者(5.1%)的 4 倍(p=0.004),1 年死亡率(PVE 29.1% vs. NVE 13.9%;p=0.020)也是 NVE 患者的 2 倍。多变量分析显示瓣周脓肿、败血症、术前急性肾损伤和 PVE 是死亡的独立风险因素。瓣周脓肿患者的 30 天死亡率(17.7%)明显高于无瓣周脓肿患者(8.0%)(p=0.003),且围手术期并发症发生率(需要术后安置起搏器、术后脑血管事件、术后急性肾损伤)更高。然而,瓣周脓肿并未影响 1 年死亡率(20.9% vs. 22.3%;p=0.806)或长期并发症,如再入院率或 IE 复发率。
与 NVE 相比,接受 PVE 手术治疗的患者 30 天和 1 年的死亡率显著更高。经倾向匹配后,PVE 患者的 30 天死亡率仍比 NVE 患者高 4 倍。瓣周脓肿患者的 30 天死亡率和围手术期并发症显著更高,而瓣周脓肿似乎对 1 年死亡率、再入院率或 IE 复发率无明显影响。